Broadview Ventures

Broadview Ventures is a mission-driven investment organisation founded in 2009 to finance companies developing technologies for the diagnosis and treatment of cardiovascular disease and stroke. The firm's stated purpose is to bridge the "translational gap" - the distance between promising laboratory science and therapies that reach patients - with a practical goal of helping innovative science through that passage.

Investment activity is concentrated at seed and Series A, spanning preclinical development through clinical proof-of-concept. The technical remit covers therapeutics, medical devices, diagnostics and digital health, with particular interest in novel mechanisms and technologies advancing cardiovascular medicine. Portfolio companies are located across North America, Europe and Israel.

Beyond capital, the organisation backs strong science and management teams and engages global leaders in science, medicine, technology and business to support them. Portfolio assistance is directed at development hurdles and strategic or operational challenges; the team itself draws on expertise in cardiovascular medicine.